Clinical Trials Directory

Trials / Completed

CompletedNCT02756338

BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment

Status
Completed
Phase
—
Study type
Observational
Enrollment
77 (actual)
Sponsor
Biotronik, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.

Conditions

Interventions

TypeNameDescription
DEVICEBioMonitor 2 Insertable Cardiac Monitor

Timeline

Start date
2016-06-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-04-29
Last updated
2018-10-26
Results posted
2018-09-10

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02756338. Inclusion in this directory is not an endorsement.

BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment (NCT02756338) · Clinical Trials Directory